Drugs for Neglected Diseases Initiative North America

Grants to research and development for Neglected Diseases: dndi North America raises funds to support dndi's research and development (r&d) activities in order to contribute to the achievement of dndi's goal of delivering 25 new treatments for Neglected patients by 2028 and establishing a robust pipeline of new potential drug candidates. Dndi now has over 30 projects in its pipeline, including over 20 potential new chemical entities (nces), and has delivered 12 treatments ofr six deadly Diseases that are already in the hands of millions of patients.

Raising public awareness and advocating for Neglected disease r&d:as part of its mission, dndi advocates for enhanced political leadership, increased resources, and an enabling policy environment to stimulate r&d for Neglected Diseases. Dndi North America actively advocates for sound policies, particularly in the united states, that will enable greater needs-driven r&d, including appropriate incentives and financing mechanisms, innovative regulatory pathways that expedite access, and open innovation approaches to intellectual property management that ensure the widest possible sharing of research knowledge and data.